Abstract:Objective To construct human glioma U251 cells with knockout of the chemokine receptor 4 (CXCR4) gene using clustered regularly interspaced short palindromic repeats/Cas9 (CRISPR/Cas9) gene editing techniques. Methods Three pairs of directed RNA [single guide RNA (sgRNA)] for target gene CXCR4 have been designed, then three groups of Cas9 expression vectors (CXCR4-sgRNA-1, CXCR4-sgRNA-2, CXCR4-sgRNA-3) were constructed by PX335 plasmid. They were sequenced and verified. The right carrier (CXCR4-sgRNA-1) was chosen and transfected into U251 cells. T7 endonuclease Ⅰ (T7E1) enzyme digestion was used to determine the knockout efficiency, and 5 groups of monoclonal cells were obtained. By sequencing and Western blotting, we obtained stable positive monoclonal cells. Results The CXCR4-sgRNA-1 group was successfully constructed. PCR enzyme digestion determined that the knockout efficiency of U251 cells after transfection was 48%, and that of no. 2, 3, 4 and 5 monoclonal cells was 20%, 40%, 30% and 20% respectively. The PCR product was sequenced after connecting the T vector, and the results showed that point mutation occurred in three groups. No. 2 had a mutation from A to G, no. 4 T to C and No. 5 A to G. A 38 bp base was inserted into the no. 3 McAb, and a meaningful mutation was identified. The CXCR4 protein expression in no. 2, 3, and 4 monoclonal cells was 0. The results of immunoblotting showed that the expression of CXCR4 protein was not detectable in the U251 cells with knockout of the CXCR4 gene, the relative expression of CXCR4 protein in knockout group was significantly lower than that of the control group (0 to 0.746±0.010, P=0.000), the difference was statistically significant. An effective knockout cell line was obtained by sequencing comparison. Conclusion The recombinant plasmid targeting CXCR4 was obtained efficiently through CRISPR/Cas9 system, and a stable U251 cell line with knockdown of CXCR4 gene was screened out. Key words: Glioma; Clustered regularly interspaced short palindromic repeats/Cas9; Chemokine receptor 4

Construction of chemokine receptor 4 knockout glioma cell line U251 by clustered regularly interspaced short palindromic repeats/Cas9

Genome Editing of CXCR4 by CRISPR/cas9 Confers Cells Resistant to HIV-1 Infection.

Generation of a TRPV1 Knockout Human Pluripotent Stem Cell Line (Wae009-a-u) Using CRISPR/Cas9.

HIV-1 Inhibition in Cells with CXCR4 Mutant Genome Created by CRISPR-Cas9 and Piggybac Recombinant Technologies.

A simple and highly efficient method for multi-allelic CRISPR-Cas9 editing in primary cell cultures

Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection

CCR5 Editing by Staphylococcus Aureus Cas9 in Human Primary CD4+ T Cells and Hematopoietic Stem/progenitor Cells Promotes HIV-1 Resistance and CD4+ T Cell Enrichment in Humanized Mice

Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system

[Intra-arterial irradiation of cerebral tumors].

Guide for generating single-cell-derived knockout clones in mammalian cell lines using the CRISPR/Cas9 system

A simple, rapid, and efficient method for generating multigene-knockout culture cells by the CRISPR/Cas9 system

Epigenetic profiles guide improved CRISPR/Cas9-mediated gene knockout in human T cells

Associative Shuffle of Infinite Words

[Construction of macrophage RAW 264.7 cells with gsdmd gene knockout by CRISPR/Cas9 system].

The CRISPR/Cas9 System Targeting EGFR Exon 17 Abrogates NF-κB Activation Via Epigenetic Modulation of UBXN1 in EGFRwt/vIII Glioma Cells

Blood-brain barrier–penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy

Universal theranostic CRISPR/Cas13a RNA-editing system for glioma

Supramolecular Nanosubstrate‐Mediated Delivery for CRISPR/Cas9 Gene Disruption and Deletion

Establishment and optimization of genome-wide CRISPR/Cas9-sgRNA screening system in THP1 cell line for functional oncogenes and tumor suppressor genes

An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue

Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapy.